Tissue microenvironment, such as injury and inflammation, impacts the formation of PDA precursor cells by mutations in proto-oncogenes and/or tumor suppressor genes, e.g., KRAS and TP53 [154]. This evidence concerns the gene KRAS and Patent ductus arteriosus.